| 前收市價 | 27.80 |
| 開市 | 28.10 |
| 買盤 | 29.05 x 500 |
| 賣出價 | 29.14 x 500 |
| 今日波幅 | 28.02 - 29.47 |
| 52 週波幅 | 18.82 - 45.58 |
| 成交量 | |
| 平均成交量 | 1,169,139 |
| 市值 | 4.254B |
| Beta 值 (5 年，每月) | 0.71 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.88 |
| 業績公佈日 | 2024年8月08日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 49.00 |
ZacksDianthus (DNTH) Gains 18% in the Past Month: Here's Why
Dianthus (DNTH) shares have rallied 18% in the past month on FDA clearance to initiate a phase II study on its lead candidate, DNTH103, to treat an autoimmune indication. Top-line data is expected in 2026.
ZacksImmunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound?
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Investor's Business DailyAfter Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
